Polymorph of a Pharmaceutical

Details for Australian Patent Application No. 2003254711 (hide)

International Classifications

Event Publications

30 October 2003 Complete Application Filed

13 November 2003 Application Open to Public Inspection

Published as AU-B-2003254711

15 March 2007 Application Accepted

Published as AU-B-2003254711

12 July 2007 Standard Patent Sealed

10 January 2008 Extension of Term of Standard Patents

Abbott Laboratories The earliest first regulatory approval date provided by the patentee 24 May 2006 For the goods Kaletra Tablets Amorphous Ritonavir

6 March 2008 Extension of Term of Standard Patents

Abbott Laboratories The earliest first regulatory approval date provided by the patentee 24 May 2006 For the goods Kaletra Tablets Amorphous Ritonavir Address for service in Australia: Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

31 July 2008 Extension granted

Abbott Laboratories The earliest first regulatory approval date provided by the patentee 24 May 2006 For the goods KALETRA lopinavir 200mg and ritonavir 50mg tablets bottle Extension of Term of patent pursuant to Section 77 expires on 24 Jul 2021

23 October 2008 Corrigenda

Extensions of Term of Standard Patent, Section 70 - Extensions Granted Under the name Abbott Laboratories, Application No. 2003254711, correct the expiration date to read 24 May 2021

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.